Israel: Israel und Iran greifen einander an Ivar AI

The Times of India

'The Donald of Dubai': UAE billionaire close to Trump bets $66 billion on AI to become the world's data king

Yahoo Entertainment

美銀示警美股6月風暴來襲，CPI年增若逾4%恐刺破科技泡沫

Businessam.be

Italiaanse bank Intesa Sanpaolo kan dankzij overname op één na grootste bank van Europa worden

36kr.com

SpaceX获得三大债券评级机构的投资级评级

PRNewswire

Flex to Join S&P 500 Index

Orf.at

US-Armee meldet neue Angriffe auf Iran

Eldiario.es

EEUU anuncia una oleada de ataques contra Irán tras el derribo de un helicóptero Apache que patrullaba el estrecho de Ormuz

Crypto Briefing

Middle East oil output slashed by 11M bpd amid Strait of Hormuz blockade: EIA

The Punch

NGX gains N830bn as Airtel Africa leads market rally

Crypto Briefing

Iran allegedly shoots down US Army Apache helicopter near Oman, triggering retaliatory strikes

El Financiero

Trump se ‘la cumple’ a Irán: Lanza ataques en represalia por derribo de helicóptero con 2 soldados de EU

Digitimes

AI demand is turning memory chips into rationed assets, Morgan Stanley says

Crypto Briefing

Cynthia Lummis calls for US to accumulate Bitcoin openly while other nations buy quietly

Diariobitcoin.com

EE. UU. ataca Irán tras caída de helicóptero estadounidense frente a Omán

Crypto Briefing

Iran launches multiple drones towards Strait of Hormuz as US shoots down four, rattling crypto markets

Crypto Briefing

Trump says Iran deal ‘very close,’ could impact troop withdrawal

The Times of India

Why is the US stock market crashing today? S&P 500 erases all gains and wipes out $1.3 trillion in 2 hours as Nasdaq and Dow turn sharply lower - Tech stocks and chip sector collapse

New York Post

Meta and Mike Rowe launch $115 trade-training program that guarantees jobs to future welders, plumbers, electricians

The Times of India

U.S. spending on rebuilding nuclear arsenal more than all other nuclear states combined including China, Russia

$Cellectis reçoit le statut RMAT de la FDA pour lasmé-cel, la première thérapie CAR-T allogénique en essai pivot pour les patients atteints de LLA-B en rechute ou réfractaire$

GlobeNewswire

Cellectis reçoit le statut RMAT de la FDA pour lasmé-cel, la première thérapie CAR-T allogénique en essai pivot pour les patients atteints de LLA-B en rechute ou réfractaire